Ist kojic dipalmitate in der Schwangerschaft sicher?
No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
Pregnancy-safe products containing kojic dipalmitate










Related ingredients
Frequently asked questions
- Ist kojic dipalmitate in der Schwangerschaft sicher?
- No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- Ist kojic dipalmitate während des Stillens sicher?
- No data indicate reproductive toxicity or lactation/breastfeeding hazards for kojic dipalmitate; parental kojic acid was not found to be a reproductive toxicant in the CIR review. Because dermal absorption of dipalmitate/derived kojic acid is low but measurable in some formulations, low systemic exposure (and therefore potential minimal transfer to breastmilk) cannot be excluded but there is no direct evidence of harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- Ist kojic dipalmitate sicher für Babyhaut?
- No infant‑specific reproductive/developmental hazard data were identified for kojic dipalmitate. Given measurable dermal uptake in some formulations in adults, the exposure score for infants is increased by +1 (immature barrier and higher surface‑area‑to‑weight). There is no evidence that baby skin exposure causes developmental toxicity, but infant dermal exposure is plausibly higher than adult for ingredients with measurable absorption. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9959276/?utm_source=openai))
- Wie bewertet VeriMom kojic dipalmitate?
- VeriMom bewertet kojic dipalmitate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu kojic dipalmitate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu kojic dipalmitate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.